NTAP Stock: Enormous Potential
The pattern that is painted on the NetApp Inc. (NASDAQ:NTAP) stock chart is quite compelling and remarkable. NTAP stock is on the verge of breaking out of one of the largest patterns I have ever come across, and the implications of a bullish breakout are enormous.
For those not familiar with my previous publications, I use technical analysis as the basis of my investment views and trading strategies. Technical analysis is based on the notion that historical price and volume data can be used to discern trends and.
The post NetApp Inc.: Chart Suggests That NTAP Stock Can Go Nuclear appeared first on Profit Confidential.... Pubdate: Tue, 24 Jan 2017 11:40:49 +0000
Is This a Threat to Qualcomm Stock (QCOM)?
Dear reader, over the last two weeks, I’ve been warning you that QUALCOMM, Inc. (NASDAQ:QCOM) may suffer damage from antitrust litigation. At first, these lawsuits weren’t having much effect on Qualcomm stock (QCOM stock), but I warned you they were serious.
Cut to this week, and you’ll see Qualcomm’s share price has fallen 11.3% (at the time of writing). Has the worst passed? Is this an opportunity to buy a great stock at bargain bin prices, or is this the start of a long-term.
The post Qualcomm Stock: The Sharks Are Circling Around QUALCOMM, Inc. appeared first on Profit Confidential.... Pubdate: Tue, 24 Jan 2017 11:38:41 +0000
Is International Business Machines Corp. a Buy?
Although it may seem counter-intuitive, International Business Machines Corp. (NYSE:IBM) could be one of the biggest winners on the stock market this year. We have this confidence in IBM stock despite a whole host of problems—19 straight quarters of declining revenues, increased competition, and an uncertain future—because none of them matter. Here’s why.
IBM is a leading player in a tech trend that could dwarf all others: artificial intelligence. This is an opportunity to make a ton of.
The post IBM Stock: Can IBM CEO Deliver on Artificial Intelligence Hype? appeared first on Profit Confidential.... Pubdate: Tue, 24 Jan 2017 11:37:12 +0000
YHOO Stock: A Constructive Advance
Yahoo! Inc. (NASDAQ:YHOO) stock has finally completed the price pattern that was the subject of my previous publication on Yahoo stock. This completion was finally accomplished when YHOO stock exited this pattern in an upward direction.
Breaking out of this pattern now suggests that the correction that ensued after YHOO stock peaked in September 2016 is complete, and a new bullish trend has commenced in which the path of least resistance is to the.
The post Yahoo! Inc.: This Is Why YHOO Stock Will Continue to Climb appeared first on Profit Confidential.... Pubdate: Tue, 24 Jan 2017 10:48:14 +0000
Apple Stock Adjusting to Trump Era
Apple Inc. (NASDAQ:AAPL) changed the landscape of mobile telephony when it launched the first generation "iPhone" ten years back. However, with the current change in political climate, Apple stock has come under pressure. Investors are looking forward to more clarity on Donald Trump’s trade policies and till then, AAPL stock may trade subdued.
But a recent report brings attention back to Apple and its Asian partners. As per the the latest news, Apple’s supplier, Foxconn Technology Group, may invest in.
The post Apple Inc.: This Could Be Good News for Apple Stock appeared first on Profit Confidential.... Pubdate: Mon, 23 Jan 2017 16:42:02 +0000
ETRM Stock on the Rise
EnteroMedics Inc (NASDAQ:ETRM) is not a stock for the faint of heart. The share prices of ETRM stock are back on top, rising by nearly 10% by the opening bell on Monday, continuing the recent spate of ups and downs in EnteroMedics stock.
There hasn't been much in the news lately that's pushed the stock back up. Earlier in January 2016, ETRM stock hit a high of $27.28 per share, a far sight away from its current value of $8.61 per share. The jump was facilitated by some good news coming out about their "vBloc" neurometabolic.
Dow Jones in a Cautious Zone
The Dow Jones Industrial Average (DJIA) may trade lower in the stock market today as Donald Trump’s Inauguration Day speech brought about more concerns than clarity on the future policies of the Trump administration. His focus on creating jobs and employment in the U.S. may result in strained relationships with other regions in the world and investors would like to wait and watch for the time being.
The DJIA index closed at 19,827.25, up about 0.5%.
The NASDAQ Composite gained 15.25 points to close at 5,555.33.
The post Stock Market Today: Market May Trade Subdued and Take a Cue from Earnings appeared first on Profit Confidential.... Pubdate: Mon, 23 Jan 2017 13:56:21 +0000
TMUS Stock: No Resistance
T-Mobile US Inc (NASDAQ:TMUS) stock is ripping higher and creating new all-time highs in the process. I've got to give this company some credit; I didn't think it could surpass the all-time high of $53.79 on its first attempt. This is the high that was created in 2007, a few short months after T-Mobile stock went public.
The new all-time high that is being created has tremendous bullish implications, and no upside resistance is just one of them. These implications are based on technical analysis. Technical analysis.
The post T-Mobile US Inc: The Sky Is the Limit for TMUS Stock appeared first on Profit Confidential.... Pubdate: Mon, 23 Jan 2017 12:53:58 +0000
Tesla Stock (TSLA)
Dear reader, you may remember that shares of Tesla Motors Inc (NASDAQ:TSLA) took a major hit last year. TSLA stock dropped below $200.00 as investors priced in effects from a horrific car accident—they believed this accident could be the downfall of Tesla stock. Here's what happened.
There was an accident involving Tesla’s "Autopilot" feature. Since this feature is the cornerstone of driverless car technology, markets interpreted it as dangerous to Tesla stock (TSLA). Unsurprisingly, the share price plunged below.
The post Tesla Stock (TSLA): Tesla Motors Inc Just Won a Big Lawsuit appeared first on Profit Confidential.... Pubdate: Mon, 23 Jan 2017 12:35:46 +0000
BMY Stock: More Pain
Bristol-Myers Squibb Co (NYSE:BMY) stock was pounded with selling pressure after a news release hit the news wires with the announcement that the company will no longer seek accelerated approval of its immunotherapy cancer drug “Opdivo." By the time the closing bell rang on Friday, January 20, BMY stock finished the day at $49.23, down 11.28%.
The negative news that sent the stock spiraling lower may have been a bit of a surprise, but the embedded trend towards lower prices in Bristol-Myers Squibb stock was definitely.
The post Bristol-Myers Squibb Co: BMY Stock Set Up for Further Losses appeared first on Profit Confidential.... Pubdate: Mon, 23 Jan 2017 12:15:58 +0000